PTGER4 and breast cancer: The immune suppressive phenotypes of myeloid cells in the lung can be reversed through ablating of COX2 in the fibroblasts, which, similar to inhibiting the PGE2 receptors EP2 and EP4, can reduce lung metastasis in several breast cancer models [38].